His scientific interests lie mostly in Immunology, Natural killer T cell, Experimental autoimmune encephalomyelitis, Antigen and CD1D. His research investigates the connection between Immunology and topics such as Interleukin 12 that intersect with issues in IL-2 receptor. His Natural killer T cell study combines topics from a wide range of disciplines, such as Cell, Cytokine and Immunity.
His Experimental autoimmune encephalomyelitis research focuses on Autoimmune disease and how it connects with Microbiome and Autoantibody. His CD1D research is multidisciplinary, relying on both Inflammation, Apolipoprotein E and Bone marrow. His biological study spans a wide range of topics, including Gut flora, Central nervous system disease, Pathology, Myelin and Neural cell adhesion molecule.
His primary areas of study are Immunology, Multiple sclerosis, Internal medicine, Experimental autoimmune encephalomyelitis and Natural killer T cell. Autoimmune disease, Antigen, Immune system, Encephalomyelitis and T cell are among the areas of Immunology where the researcher is concentrating his efforts. His work in the fields of Multiple sclerosis, such as Neuromyelitis optica and Expanded Disability Status Scale, intersects with other areas such as Spectrum disorder.
His research in Internal medicine focuses on subjects like Endocrinology, which are connected to Receptor. He has included themes like Proinflammatory cytokine and Interleukin 17 in his Experimental autoimmune encephalomyelitis study. His Natural killer T cell research includes elements of Glycolipid, Cell and Cytokine.
The scientist’s investigation covers issues in Multiple sclerosis, Immunology, Neuromyelitis optica, Spectrum disorder and Internal medicine. His Multiple sclerosis research is multidisciplinary, incorporating elements of Microvesicles and Disease. His Immune system, Encephalomyelitis, Experimental autoimmune encephalomyelitis, Dysbiosis and Pathogenesis study are his primary interests in Immunology.
His work in Experimental autoimmune encephalomyelitis tackles topics such as LAG3 which are related to areas like Intraepithelial lymphocyte and Autoimmunity. Takashi Yamamura combines subjects such as Dermatology, Relapse prevention, Tocilizumab and Foveal with his study of Neuromyelitis optica. His work deals with themes such as Gastroenterology and Neuroimaging, which intersect with Internal medicine.
His main research concerns Multiple sclerosis, Immunology, Neuromyelitis optica, Spectrum disorder and Internal medicine. His Multiple sclerosis study incorporates themes from Receptor, Gene and FOXP3. His study involves Immune system, Experimental autoimmune encephalomyelitis, Cytokine, Proinflammatory cytokine and Integrin alpha M, a branch of Immunology.
His Experimental autoimmune encephalomyelitis study integrates concerns from other disciplines, such as MHC class II, Neuroinflammation, Antibody, Intraepithelial lymphocyte and LAG3. His Neuromyelitis optica research is multidisciplinary, incorporating perspectives in Ophthalmology, Retinal, Foveal and Expanded Disability Status Scale. He focuses mostly in the field of Internal medicine, narrowing it down to matters related to Gastroenterology and, in some cases, Neuroimaging, Differential diagnosis, Diffusion MRI, Fractional anisotropy and Plasmapheresis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.
Katsuichi Miyamoto;Sachiko Miyake;Takashi Yamamura.
Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters
Sachiko Miyake;Sangwan Kim;Wataru Suda;Kenshiro Oshima.
PLOS ONE (2015)
Thyrotrophin in the pars tuberalis triggers photoperiodic response
Nobuhiro Nakao;Hiroko Ono;Takashi Yamamura;Tsubasa Anraku.
Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides
Karl O. A. Yu;Jin S. Im;Alberto Molano;Yves Dutronc.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells.
Katarzyna Maresz;Gareth Pryce;Gareth Pryce;Eugene D Ponomarev;Giovanni Marsicano.
Nature Medicine (2007)
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
Norio Chihara;Toshimasa Aranami;Wakiro Sato;Yusei Miyazaki.
Proceedings of the National Academy of Sciences of the United States of America (2011)
Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy.
Zsolt Illés;Takayuki Kondo;Jia Newcombe;Nobuyuki Oka.
Journal of Immunology (2000)
Efficacy of the anti–IL-6 receptor antibody tocilizumab in neuromyelitis optica A pilot study
Manabu Araki;Takako Matsuoka;Katsuichi Miyamoto;Susumu Kusunoki.
Cannabinoids and the immune system : Potential for the treatment of inflammatory diseases?
J. Ludovic Croxford;Takashi Yamamura.
Journal of Neuroimmunology (2005)
Th17 Cells and Autoimmune Encephalomyelitis (EAE/MS)
Toshimasa Aranami;Takashi Yamamura.
Allergology International (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: